Amprenavir is the fifth protease inhibitor (PI) to be approved for the treatment of individuals with HIV infection. Amprenavir plus 2 nucleoside reverse transcriptase inhibitors (NRTIs ...
Virological data suggest that many patients failing therapy with other protease inhibitors remain susceptible to amprenavir indicating a role for amprenavir in 'rescue' antiretroviral combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback